繁體
  • 简体中文
  • 繁體中文

熱門資訊> 正文

Pulmatrix GAAP每股收益为-0.29美元

2026-08-13 20:17

  • Pulmatrix press release (PULM): Q2 GAAP EPS of -$0.29.
  • The Company's total cash and cash equivalents balance as of June 30, 2026, was $2.2 million, in addition to $0.7 million in restricted cash that would become unrestricted following consummation of the Merger, as compared to $4.1 million as of December 31, 2025. 

風險及免責提示:以上內容僅代表作者的個人立場和觀點,不代表華盛的任何立場,華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前,應結合自身情況,考慮投資產品的風險。必要時,請諮詢專業投資顧問的意見。華盛不提供任何投資建議,對此亦不做任何承諾和保證。